Evidence map›Paper›PMID 41477370›Full record

ReviewCureus2025

Artificial Intelligence-Integrated Biosensors for Antimicrobial Resistance Detection and Surveillance: A Review and Future Perspectives for Global Biosecurity.

Olabisi P Lawal, Innocent J Opara, Ayodele Ayo-Ige, Ndidi A Eboh, Uchechukwu Cos-Ibe, Kwesi Akonu Adom Mensah Forson, Elijah Kordieh Mensah, Ololade F Olaitan, Enoch Nii-Okai, Alfred Yeboah and 2 more

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Olabisi P LawalMedical Laboratory Science, University of Benin, Benin City, NGA.
Innocent J OparaComputer Information Systems, Prairie View A&M University, Prairie View, USA.
Ayodele Ayo-IgeInfectious Diseases, Yale University, New Haven, USA.
Ndidi A EbohNursing, Stark State College, North Canton, USA.
Uchechukwu Cos-IbeComputer Science, Georgia State University, Atlanta, USA.
Kwesi Akonu Adom Mensah ForsonBiology, University of Virginia, Charlottesville, USA.
Elijah Kordieh MensahEnvironmental Studies, University of Montana, Missoula, USA.
Ololade F OlaitanInformation Systems, University of Utah, Salt Lake City, USA.
Enoch Nii-OkaiMining and Minerals Engineering, Michigan Technological University, Houghton, USA.
Alfred YeboahMining and Minerals Engineering, Michigan Technological University, Houghton, USA.
Nazeem GabrielsEmergency Medicine, Stockport National Health Service (NHS) Foundation Trust, Stockport, GBR.
Aliyu O OlaniyiGeriatrics, Stepping Hill Hospital, Stockport, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) poses a critical threat to global health, undermining the efficacy of modern medicine. The escalating global epidemic of AMR jeopardizes the efficacy of contemporary medicine and undermines health systems globally. The swift, precise, and scalable identification of resistance determinants is essential for containment and stewardship initiatives; yet, existing surveillance techniques are constrained by time, expense, and accessibility. Recent advancements in biosensor technology and artificial intelligence (AI) provide a revolutionary approach to decentralized, intelligent AMR monitoring. This review consolidates recent advancements in biosensor platforms-encompassing electrochemical, optical, piezoelectric, paper-based, and nanomaterial-based modalities-and their incorporation with AI and machine learning techniques for improved detection, signal interpretation, and predictive analytics. This study investigates the utilization of hybrid systems in clinical, veterinary, and environmental settings under the One Health surveillance framework. The research also examines the integration of AI-enabled biosensors within digital and Internet of Things (IoT) frameworks, emphasizing its capacity to produce real-time, data-intensive insights for public health decision-making. Critical analysis is conducted on key problems, including sensor repeatability, data scarcity, algorithmic transparency, and regulatory adaptation, in conjunction with socioeconomic and ethical considerations. The report delineates prospective avenues for research, policy, and implementation, highlighting open data standards, equitable access, and interdisciplinary collaboration. These breakthroughs collectively indicate the emergence of AI-driven biosensing networks, which provide predictive, adaptive, and globally coordinated AMR surveillance.

Indexed as

antimicrobial resistance (amr)artificial intelligence (ai)biosensorsmachine learning (ml)one health

Identifiers

PMID41477370
PMCPMC12750469

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.